Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Other Chemical drugs >  Esaxerenone

Esaxerenone

Basic information Safety Supplier Related

Esaxerenone Basic information

Product Name:
Esaxerenone
Synonyms:
  • cs3150
  • cs-3150
  • Esaxerenone
  • CS-3150 (Esaxerenone
  • XL-550)
  • CS-2614
  • 5G,100G,500G
  • CS-3150; CS 3150; CS3150; XL-550; XL550; XL 550.
CAS:
1632006-28-0
MF:
C22H21F3N2O4S
MW:
466.48
Mol File:
1632006-28-0.mol
More
Less

Esaxerenone Chemical Properties

Boiling point:
581.3±50.0 °C(Predicted)
Density 
1.35±0.1 g/cm3(Predicted)
solubility 
DMSO:100.0(Max Conc. mg/mL);214.37(Max Conc. mM)
pka
12.76±0.70(Predicted)
form 
Solid
color 
White to light yellow
InChI
InChI=1S/C22H21F3N2O4S/c1-14-18(21(29)26-15-7-9-16(10-8-15)32(2,30)31)13-27(11-12-28)20(14)17-5-3-4-6-19(17)22(23,24)25/h3-10,13,28H,11-12H2,1-2H3,(H,26,29)
InChIKey
NOSNHVJANRODGR-UHFFFAOYSA-N
SMILES
C(N1C=C(C(=O)NC2C=CC(S(=O)(=O)C)=CC=2)C(C)=C1C1C=CC=CC=1C(F)(F)F)CO
More
Less

Esaxerenone Usage And Synthesis

Uses

Esaxerenone, is a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist.

Biological Activity

Esaxerenone exerts its antihypertensive effect by blocking excessive activation of the mineralocorticoid receptor by endogenous ligands (such as aldosterone), has a mineralocorticoid receptor selectivity at least 1000-fold greater than other steroid hormone receptors, a long half-life, high oral bioavailability, and has a more significant antihypertensive effect than spironolactone or eplerenone.

Synthesis

below shows the synthesis route of Esaxerenone

in vivo

After single oral administration of Esaxerenone at 0.1, 0.3, 1, and 3?mg/kg, maximum plasma concentration (Cmax) and the area under the plasma concentration versus time curve (AUC) are increased with dose. Time to reach the maximum plasma concentration (Tmax) of Esaxerenone ranges from 2.0 to 4.5?h. After intravenous administration of Esaxerenone at 0.1, 0.3, 1, and 3?mg/kg, the total body clearance (CL) and distribution volume at steady state (Vss) are 3.53 to 6.69?mL/min/kg and 1.47 to 2.49?L/kg, respectively, in rats, and 2.79 to 3.69?mL/min/kg and 1.34 to 1.54?L/kg, respectively, in cynomolgus monkeys. Up to 168?h after administration, 3.9% and 91.4% of dosed radioactivity are excreted in rat urine and feces, respectively, and 95.2% in total. In monkeys, the excreted radioactivity up to 168?h is 11.5% in urine, 82.3% in feces, and 93.9% in total[1].

EsaxerenoneSupplier

Nanjing Vcare PharmaTech Co., Ltd Gold
Tel
025-58741518 13327700685
Email
sales@vcarepharmatech.com
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Tel
17702719238 18971495150;
Email
sales@sun-shinechem.com
Shanghai Famo Bio-chemical Technology Company Ltd.
Tel
021-02136680027 15800370750
Email
1706640024@qq.com
Taizhou Tongxin Bio-Tech Co., Ltd
Tel
0523-86818997 18652728585
Email
sales@allyrise.com
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266